These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 15210067

  • 1. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
    Chen XH, Bai JY, Shen F, Bai AP, Guo ZR, Cheng GF.
    Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
    [Abstract] [Full Text] [Related]

  • 2. [Inhibitory effects of benzoisoselenothiazolidone sulfonamide derivatives on cyclooxygenase].
    Guo Y, Xiao YX, Guo ZR, Cheng GF.
    Yao Xue Xue Bao; 2001 Oct; 36(10):735-8. PubMed ID: 12579970
    [Abstract] [Full Text] [Related]

  • 3. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
    Kalgutkar AS, Kozak KR, Crews BC, Hochgesang GP, Marnett LJ.
    J Med Chem; 1998 Nov 19; 41(24):4800-18. PubMed ID: 9822550
    [Abstract] [Full Text] [Related]

  • 4. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S, Kennedy B, Leblanc Y, Leger S, Mancini J, O'Neill GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasit P, Rodger I.
    J Pharmacol Exp Ther; 1999 Aug 19; 290(2):551-60. PubMed ID: 10411562
    [Abstract] [Full Text] [Related]

  • 5. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T, Shearer T, Azuma M.
    Curr Eye Res; 2004 Jul 19; 29(1):27-34. PubMed ID: 15370364
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effect of 3,4-diaryl-3-pyrrolin-2-one derivatives on cyclooxygenase 1 and 2 in murine peritoneal macrophages.
    Shen F, Bai AP, Guo ZR, Cheng GF.
    Acta Pharmacol Sin; 2002 Aug 19; 23(8):762-8. PubMed ID: 12147201
    [Abstract] [Full Text] [Related]

  • 7. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
    Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn TA.
    J Orthop Res; 2003 Jul 19; 21(4):670-5. PubMed ID: 12798067
    [Abstract] [Full Text] [Related]

  • 8. 1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2.
    Khanna IK, Weier RM, Yu Y, Collins PW, Miyashiro JM, Koboldt CM, Veenhuizen AW, Currie JL, Seibert K, Isakson PC.
    J Med Chem; 1997 May 23; 40(11):1619-33. PubMed ID: 9171872
    [Abstract] [Full Text] [Related]

  • 9. Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase.
    Chung EY, Kim BH, Lee MK, Yun YP, Lee SH, Min KR, Kim Y.
    Planta Med; 2003 Aug 23; 69(8):710-4. PubMed ID: 14531020
    [Abstract] [Full Text] [Related]

  • 10. Cloning, expression, and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2.
    Gierse JK, Staten NR, Casperson GF, Koboldt CM, Trigg JS, Reitz BA, Pierce JL, Seibert K.
    Vet Ther; 2002 Aug 23; 3(3):270-80. PubMed ID: 12447834
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of cyclooxygenase-2 with antisense oligodeoxynucleotide restricts induction of rat adjuvant-induced arthritis.
    Yamada R, Sano H, Hla T, Hashiramoto A, Kawahito Y, Mukai S, Kohno M, Tsubouchi Y, Inoue M, Komatsu A, Inoue K, Kondo M.
    Biochem Biophys Res Commun; 2000 Mar 16; 269(2):415-21. PubMed ID: 10708568
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation.
    Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, Mestre JR, Grunberger D, Sacks PG, Tanabe T, Dannenberg AJ.
    Cancer Res; 1999 May 15; 59(10):2347-52. PubMed ID: 10344742
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
    Song Y, Connor DT, Sercel AD, Sorenson RJ, Doubleday R, Unangst PC, Roth BD, Beylin VG, Gilbertsen RB, Chan K, Schrier DJ, Guglietta A, Bornemeier DA, Dyer RD.
    J Med Chem; 1999 Apr 08; 42(7):1161-9. PubMed ID: 10197960
    [Abstract] [Full Text] [Related]

  • 14. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A, Cavalcanti F, Miralles A, Bayón Y, Alonso A, Merlos M, García-Rafanell J, Forn J.
    Mol Pharmacol; 1999 Apr 15; 55(4):753-60. PubMed ID: 10101034
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y, Connor DT, Doubleday R, Sorenson RJ, Sercel AD, Unangst PC, Roth BD, Gilbertsen RB, Chan K, Schrier DJ, Guglietta A, Bornemeier DA, Dyer RD.
    J Med Chem; 1999 Apr 08; 42(7):1151-60. PubMed ID: 10197959
    [Abstract] [Full Text] [Related]

  • 18. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA.
    Nat Med; 1999 Jun 08; 5(6):698-701. PubMed ID: 10371510
    [Abstract] [Full Text] [Related]

  • 19. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
    Muscará MN, McKnight W, Asfaha S, Wallace JL.
    Br J Pharmacol; 2000 Feb 08; 129(4):681-6. PubMed ID: 10683192
    [Abstract] [Full Text] [Related]

  • 20. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
    Gierse JK, Zhang Y, Hood WF, Walker MC, Trigg JS, Maziasz TJ, Koboldt CM, Muhammad JL, Zweifel BS, Masferrer JL, Isakson PC, Seibert K.
    J Pharmacol Exp Ther; 2005 Mar 08; 312(3):1206-12. PubMed ID: 15494548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.